Associated Genetic Biomarkers
ZAP70 status serves as an inclusion eligibility criteria in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial that contains ZAP70 status as an inclusion criterion, 1 is phase 2 (1 open).
The most frequent alteration to serve as an inclusion eligibility criterion is ZAP70 Expression .
Significance of ZAP70 in Diseases
Chronic Lymphocytic Leukemia +
ZAP70 is an inclusion criterion in 1 clinical trial for chronic lymphocytic leukemia, of which 1 is open and 0 are closed. Of the trial that contains ZAP70 status and chronic lymphocytic leukemia as inclusion criteria, 1 is phase 2 (1 open) .
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.